Hyperimmune immunoglobulin for people with COVID‐19 – Kimber, C – 2023 | Cochrane Library

Collapse all Expand all Background Hyperimmune immunoglobulin (hIVIG) contains polyclonal antibodies, which can be prepared from large amounts of pooled convalescent plasma or prepared from animal sources through immunisation. They are being investigated as a potential therapy for coronavirus disease 2019 (COVID‐19). This review was previously part of a parent review addressing…

Read the full article here

Related Articles